GleamWall
中文EN

AXGN Axogen, Inc.

Electromedical & Electrotherapeutic Apparatus · Nasdaq · SEC CIK 805928 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY24.3%
TTM net income YoY-1,422.3%
TTM EPS YoY-1,160.0%
Revenue 3-yr CAGR20.6%
Net income 3-yr CAGR—

Margins

Gross margin74.2%
Operating margin-5.2%
Net margin-12.0%
FCF margin8.3%
EBITDA margin-2.8%

Returns

ROE-10.3%
ROA-8.3%
ROIC (approx.)-7.1%
Asset turnover0.70x

Leverage & solvency

Liabilities / assets9.9%
Debt / equity0.00x
Current ratio12.02x
Interest coverage-5.72x

Cash quality & payout

Operating cash flow / net income-0.89x
Accruals ratio-15.7%
Payout ratio—
Capex / revenue2.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$225.21M$187.34M
Cost of revenue$57.85M$45.36M
Gross profit$167.35M$141.98M
R&D expense$32.88M$27.77M
SG&A expense$44.58M$39.04M
Operating income-$7.85M-$3.29M
Interest expense$7.70M$8.21M
Income tax$0$0
Net income-$15.70M-$9.96M
EBITDA-$1.19M$3.18M
EPS (basic)-0.34-0.23
EPS (diluted)-0.34-0.23
Weighted avg. shares (diluted)46.05M44.26M
Balance sheet
Cash & equivalents$35.55M$33.55M
Short-term investments$5.98M$5.93M
Receivables$26.17M$24.11M
Inventory$42.37M$33.18M
Current assets$120.42M$99.22M
PP&E, net$81.78M$84.67M
Intangibles$6.75M$5.58M
Total assets$221.69M$203.73M
Current liabilities$23.56M$30.61M
Long-term debt$48.39M$47.50M
Total debt$48.39M$47.50M
Total liabilities$92.84M$99.82M
Shareholders' equity$128.85M$103.91M
Net debt$12.84M$13.94M
Shares outstanding47.20M44.15M
Cash flow statement
Operating cash flow$812,000$4.54M
Capital expenditure$3.75M$3.10M
Free cash flow-$2.93M$1.43M
Investing cash flow-$5.32M-$10.30M
Financing cash flow$10.50M$2.29M
Depreciation & amortization$6.66M$6.47M
Stock-based compensation$30.11M$15.91M

Free plan shows the latest 2 periods; Pro shows all 16 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.